Nav: Home

Research suggests coffee associated with approx 25 percent lower risk of type 2 diabetes

November 13, 2018

A report from the Institute for Scientific Information on Coffee (ISIC) titled ' Coffee and type 2 diabetes: A review of the latest research' highlights the potential role of coffee consumption on the reduced risk of developing type 2 diabetes, and the potential mechanisms involved.

Eminent experts in diabetes gathered at a satellite symposium hosted by The Institute for Scientific Information on Coffee (ISIC) at the European Association for the Study of Diabetes (EASD) 2018 Annual Meeting in Berlin, Germany, to discuss the latest research on coffee consumption and type 2 diabetes.

During the symposium, Associate Professor Mattias Carlström reviewed the latest scientific research on the association between coffee consumption and type 2 diabetes risk; including his own meta-analysis of the data entitled 'Coffee consumption and reduced risk of developing type 2 diabetes' which looked at 30 prospective studies, with a total of 1,185,210 participants.1

Professor Kjeld Hermansen explored the potential mechanistic perspectives behind the inverse association between coffee consumption and T2D, presenting a summary of the research that has been undertaken in this area. The research suggests that a number of factors may be involved including an antioxidant effect, an anti-inflammatory effect, thermogenic effects or the modulation of microbiome diversity. Professor Hermansen's presentation also drew on his own research into coffee compounds such as caffeic acid and cafestol.

Key research findings highlighted in the roundtable report include:
  • Meta-analyses have suggested that drinking 3-4 cups of coffee per day is associated with an approximate 25% lower risk of developing type 2 diabetes2,3
  • The inverse association between coffee consumption and type 2 diabetes was shown in both men and women1
  • Meta-analyses has suggested that both caffeinated and decaffeinated coffee are associated with a reduced risk of type 2 diabetes1,2,3
  • A number of potentially clinically relevant compounds are present in coffee, including: caffeine, hydroxycinnamic acids notably chlorogenic acid, trigonelline, diterpenes eg cafestol and kahweol, and caffeic acid


To read the report titled, 'Coffee and type 2 diabetes: A review of the latest research', click [LINK].
-end-
Readers interested in finding out more about coffee & health can visit: http://www.coffeeandhealth.org

Notes to editors
  • Moderate coffee consumption can be defined as 3-5 cups per day, based on the European Food Safety Authority's review of caffeine safety4.
  • To read a full overview of coffee and type 2 diabetes, click here.


Symposium speakers
  • Associate Professor Mattias Carlström, Department of Physiology and Pharmacology, Karolinska Institutet, Sweden
  • Professor Kjeld Hermansen, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark


References

1. Carlström M., Larsson S.C. (2018) Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev, 76(6):395-417
2. Huxley R. et al. (2009) Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus. Arch Int Med, 169:2053-2063.
3. Ding M. et al. (2014) Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: A systematic review and dose response meta-analysis. Diab Care, 37(2):569-586.
4. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) (2015) Scientific Opinion on the safety of caffeine. EFSA Journal, 13(5):4102.

About ISIC

The Institute for Scientific Information on Coffee (ISIC) is a not-for-profit organization, established in 1990 and devoted to the study and disclosure of science related to "coffee and health." Since 2003 ISIC also supports a pan-European education programme, working in partnership with national coffee associations in nine countries to convey current scientific knowledge on "coffee and health" to health care professionals.

ISIC's activities are focused on:
  • the study of scientific matters related to "coffee and health"
  • the collection and evaluation of studies and scientific information about "coffee and health"
  • the support of independent scientific research on "coffee and health"
  • active dissemination of balanced "coffee and health" scientific research and knowledge to a broad range of stakeholders.


ISIC respects scientific research ethics in all its activities. ISIC's communications are based on sound science and rely on scientific studies derived from peer-reviewed scientific journals and other publications.

ISIC members are six of the major European coffee companies: illycaffè, Jacobs Douwe Egberts, Lavazza,Nestlé, Paulig, and Tchibo.

About coffeeandhealth.org

The website http://www.coffeeandhealth.org is a science-based resource developed for health care and other professional audiences and provides the latest information and research into coffee, caffeine and health.

Follow us on twitter: @coffeeandhealth

The Institute for Scientific Information on Coffee (ISIC)

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...